Arthur Sands
Vermögen: 16 Mio $ am 31.05.2026
Vermögen: 16 Mio $ am 31.05.2026
Arthur T.
Sands was the founder of Lexicon Pharmaceuticals, Inc., founded in 1995, where the titles held included President, Chief Executive Officer & Director from 2011 to 2014.
Current jobs include President, Chief Executive Officer & Director at Nurix Therapeutics, Inc. since 2014, with the CEO title starting in 2020, and Director at Biotechnology Innovation Organization.
Former job includes Director at Symphony Icon, Inc. Education history includes undergraduate studies at Yale University and graduate and doctorate degrees from Baylor College of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NURIX THERAPEUTICS, INC. 0,88 % | 20.03.2026 | 908.333 ( 0,88 % ) | 16 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Vorstandsvorsitzender | 18.09.2014 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Gründer | 07.07.2014 |
Symphony Icon, Inc.
Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphony Icon, Inc.
Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen